期刊文献+

糖化血红蛋白对精神分裂症患者糖尿病筛查的临床价值 被引量:1

Clinical Significance of HbA1c in Screening of Schizophreniac Mellitus
下载PDF
导出
摘要 目的评估糖化血红蛋白(Hb A1c)在精神分裂症糖尿病筛查中应用的可能性。方法对同时进行75g口服葡萄糖耐量试验(OGTT)和Hb A1c检查的368例精神分裂症患者按美国糖尿病协会(ADA)标准分为糖尿病组(42例)和非糖尿病(326例),分析两组Hb A1c结果。结果糖尿病组Hb A1c水平明显高于非糖尿病组(P<0.01);Hb A1c筛查精神分裂症糖尿病的受试者工作特征(ROC)曲线下面积为0.969;当Hb A1c的Cut-off值为5.4%时,筛查糖尿病的敏感性为73.0%、特异性为98.4%、阳性预示值为75.9%、可靠性为98.2%。结论 Hb A1c可作为一个非常有希望的用于精神分裂症糖尿病筛查指标。
作者 王浩
机构地区 江西省精神病院
出处 《现代诊断与治疗》 CAS 2014年第15期3382-3384,共3页 Modern Diagnosis and Treatment
  • 相关文献

参考文献7

  • 1Mackin P.Cardiac side effects of psychiatric drugs[J].Human Psychopharmacology:Clinical and Experimental,2008,23(S1):S3-S14.
  • 2Galletly CA,Foley DL,Waterreus A,et al.Cardiometabolic risk factors in people with psychotic disorders:The second Australian national survey of psychosis[J].Australian and New Zealand Journal of Psychiatry,2012,46(8):753-761.
  • 3Hennekens CH.Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia[J].The Journal of clinical psychiatry,2007,68(3):24.
  • 4Meyer JM.Antipsychotics and metabolics in the post-CATIE era[J].Behavioral Neurobiology of Schizophrenia and Its Treatment,2010,36(9):23-42.
  • 5De Hert M,Schreurs V,Sweers K,et al.Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia:a retrospective chart review[J].Schizophrenia Research,2008,101(1):295-303.
  • 6Hennekens CH,Hennekens AR,Hollar D,et al.Schizophrenia and increased risks of cardiovascular disease[J].American heart journal,2005,150(6):1115-21.
  • 7俞春芳,葛军,李静怡,孟健,刘文斌,刘均均.糖化血红蛋白和空腹血糖用于早期筛查糖尿病的意义[J].中华内分泌代谢杂志,2011,27(5):390-392. 被引量:38

二级参考文献12

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 2Bennet CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med, 2007, 24 : 333-343.
  • 3Saudek CD,Herman WH,Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab ,2008,93 : 2447- 2453.
  • 4World Health Organization : Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva:World Health Organization,1999.
  • 5Wahl PW, Savage PJ, Psaty BM, et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet, 1998,352 : 1012-1015.
  • 6Gomez-Perez FJ, Aguilar-salinas CA, Lopez-Alvarenga JC, et al. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care, 1998, 21: 1886-1888.
  • 7Deepa R, Shanthi Rani S, Premalatha G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians-the Chennai Urban Population Study. American Diabetes Association. Diabet Med, 2000,17 : 872-874.
  • 8Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring, Diabetes Care, 1998,21:261-264.
  • 9International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care, 2009,32 : 1327-1334.
  • 10Kim KS, Kim SK, Lee YK, et al. Diagnostic value of glycated haemoglobin( HbA1c ) for the early detection of diabetes in high-risk subjects. Diabet Med, 2008,25:997-1000.

共引文献37

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部